Cargando…
A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinoma
Engagement of the mitochondrial-death amplification pathway is an essential component in chemotherapeutic execution of cancer cells. Therefore, identification of mitochondria-targeting agents has become an attractive avenue for novel drug discovery. Here, we report the anticancer activity of a novel...
Autores principales: | Maillet, A, Yadav, S, Loo, Y L, Sachaphibulkij, K, Pervaiz, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698552/ https://www.ncbi.nlm.nih.gov/pubmed/23744353 http://dx.doi.org/10.1038/cddis.2013.185 |
Ejemplares similares
-
Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer
por: Liang, Wenquan, et al.
Publicado: (2017) -
OSMIUM STAINING OF ENDOPLASMIC RETICULUM AND MITOCHONDRIA IN THE RAT ADRENAL CORTEX
por: Friend, Daniel S., et al.
Publicado: (1970) -
Towards Water Soluble Mitochondria-Targeting Theranostic Osmium(II) Triazole-Based Complexes
por: Omar, Salem A. E., et al.
Publicado: (2016) -
Autophagy-Regulated ROS from Xanthine Oxidase Acts as an Early Effector for Triggering Late Mitochondria-Dependent Apoptosis in Cathepsin S-Targeted Tumor Cells
por: Huang, Chien-Chang, et al.
Publicado: (2015) -
Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells
por: Seah, S, et al.
Publicado: (2015)